Immunoglobulin G1, anti-(human neuregulin receptor HER3) (human monoclonal U3-1287 heavy chain), disulfide with human monoclonal U3-1287 κ-chain, dimer;Patritumab;Research Grade Patritumab (DHD48404);Patritumab (anti-ERBB3);U3-1287|||AMG-888;Research Grade Patritumab
用途
Patritumab is a neutralizing monoclonal antibody targeting ERBB3; it synergizes with Cetuximab to effectively inhibit phosphorylation of EGFR, HER2, HER3, ERK, and AKT; it also induces apoptosis and inhibits tumor growth in xenograft models of pancreatic, non-small cell lung, and colorectal cancers.